NCT02656017 Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease Status COMPLETED Phase PHASE2
NCT02647827 Acupuncture or Metformin for Insulin Resistance in Women With PCOS Status RECRUITING Phase PHASE2
NCT02644954 Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis Status UNKNOWN Phase PHASE3
NCT02644577 Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients Status COMPLETED Phase PHASE4
NCT02640534 Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone Status TERMINATED Phase PHASE2
NCT02638805 Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide Status COMPLETED Phase PHASE3
NCT02633488 Effect of Metformin on Insulin Sensitivity and Pan-Arterial Vascular Function in Adults With Metabolic Syndrome Status COMPLETED Phase NA
NCT02630706 A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012) Status COMPLETED Phase PHASE3
NCT02629627 Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome Status COMPLETED Phase PHASE2
NCT02621489 Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects Status COMPLETED Phase PHASE4
NCT02614339 Effect of Adjunctive Metformin on Recurrence of Non-DM Colorectal Cancer Stage II High-risk/ III Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT02611518 A Pharmacokinetic Interaction Study Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin in Healthy Participants Status COMPLETED Phase PHASE1
NCT02605772 Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes Status UNKNOWN Phase PHASE4
NCT02597400 Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM Status COMPLETED Phase PHASE1
NCT02597101 Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT02597049 A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT02587741 Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens Status UNKNOWN Phase EARLY_PHASE1
NCT02586129 Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes Status COMPLETED Phase PHASE3